Exosomes derived from pancreatic cancer CAFs increase the release of exosomes upon gemcitabine treatment, which in turn induces chemoresistance in pancreatic cancer cells by modulating the expression of Snail and miR-146a. This evidence concerns the gene SNAI1 and pancreatic neoplasm.